MONKEYPOX TREATMENT MARKET ANALYSIS

Monkeypox Treatment Market, by Treatment Type (Prophylactic (vaccines), Therapeutics (Tecovirimat, Brincidofovir, Cidofovir)), by Route of Administration (Oral, Injectable), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Sep 2022
Code : CMI5199
Pages :184
Formats :
Excel and PDF
Industry : Pharmaceutical

Monkeypox Treatment MarketSize and Trends

Global monkeypox treatment market is estimated to be valued at US$ 70.4 Million in 2022 and expected to reach US$ 258.6 million by 2030, witnessing a CAGR of 17.7 % over the forecast period (2022-2030).

Figure 1. Global Monkeypox Treatment Market Share (%), By Region, 2022

Increase in the prevalence of monkeypox disease is expected to drive growth of the global monkeypox treatment market

The increasing incidence of monkeypox disease is expected to drive the demand for new drugs and vaccines for the treatment of this disease. This is further expected to drive the global monkeypox treatment market growth over the forecast period.

For instance, according to data published by Centers for Disease Control and Prevention, till 9 August 2022, there are confirmed 31,800 total cases of monkeypox, worldwide, out of which 31,425 are in countries that have not historically reported monkeypox. While, 375 in countries that have historically reported monkeypox.

Figure 2. Global Monkeypox Treatment Market Share (%) Analysis, By Treatment Type, 2022